These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37214171)

  • 1. Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps.
    Braid J; Islam L; Gugiu C; Omachi TA; Doll H
    World Allergy Organ J; 2023 May; 16(5):100776. PubMed ID: 37214171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis.
    Damask C; Chen M; Holweg CTJ; Yoo B; Millette LA; Franzese C
    Am J Rhinol Allergy; 2022 Jan; 36(1):135-141. PubMed ID: 34382434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial.
    Zhang Y; Yan B; Shen S; Song X; Jiang Y; Shi L; Zhao C; Yang Y; Jiang L; Li J; Ye J; Liu J; Wan L; Yang Y; Chen J; Liu F; Su L; Xu Y; Tan G; Yu S; Zhang Y; Wang L; Liu S; Yan H; Liu W; Chen B; Wang C; Zhang L
    EClinicalMedicine; 2023 Jul; 61():102076. PubMed ID: 37483544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
    Peters AT; Han JK; Hellings P; Heffler E; Gevaert P; Bachert C; Xu Y; Chuang CC; Neupane B; Msihid J; Mannent LP; Guyot P; Kamat S
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2461-2471.e5. PubMed ID: 33548517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
    Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
    J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis.
    Lombardo N; Piazzetta GL; Lobello N; Cicala G; Patafi M; Benincasa AT; Pelaia C; Chiarella E; Pelaia G
    J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38276218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
    Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
    Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.
    Han JK; Bachert C; Lee SE; Hopkins C; Heffler E; Hellings PW; Peters AT; Kamat S; Whalley D; Qin S; Nelson L; Siddiqui S; Khan AH; Li Y; Mannent LP; Guillemin I; Chuang CC
    Laryngoscope; 2022 Feb; 132(2):265-271. PubMed ID: 34850966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal Polyps.
    Ow RA; McGinnis JP; Sacks HJ; Mehle ME
    Ear Nose Throat J; 2022 Apr; ():1455613221088698. PubMed ID: 35437059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
    Shih VH; Slagle AF; Ivanescu C; Flore G; Meyers O; Kreindler J; Martin UJ; Werkström V
    Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1638-1648. PubMed ID: 37271980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
    Armengot-Carceller M; Gómez-Gómez MJ; García-Navalón C; Doménech-Campos E; Muñoz-Fernández N; Miguel AG; Marco-Algarra J; Palop-Cervera M; Piñero AG
    Am J Rhinol Allergy; 2021 Jul; 35(4):516-524. PubMed ID: 33153272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
    Geng B; Dilley M; Anterasian C
    Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
    Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis.
    Cai S; Xu S; Lou H; Zhang L
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1876-1886.e7. PubMed ID: 35272073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study.
    Gevaert P; Saenz R; Corren J; Han JK; Mullol J; Lee SE; Ow RA; Zhao R; Howard M; Wong K; Islam L; Ligueros-Saylan M; Omachi TA; Bachert C
    J Allergy Clin Immunol; 2022 Mar; 149(3):957-965.e3. PubMed ID: 34530020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray.
    Rozjabek H; Li N; Hartmann H; Fu DJ; Canuso C; Jamieson C
    J Patient Rep Outcomes; 2022 Jul; 6(1):74. PubMed ID: 35816217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.